树鼩经甲型肝炎减毒活疫苗、乙型肝炎疫苗及联合硫酸乙酰肝素佐剂免疫后的免疫效果评价

doi:10.3969/j.issn.1674-5817.2017.02.006

实验动物与比较医学 ›› 2017, Vol. 37 ›› Issue (2): 113-117.DOI: 10.3969/j.issn.1674-5817.2017.02.006

树鼩经甲型肝炎减毒活疫苗、乙型肝炎疫苗及联合硫酸乙酰肝素佐剂免疫后的免疫效果评价

王东宝, 胡云章, 胡凝珠, 罕园园, 匡德宣, 李彦涵

中国医学科学院北京协和医学院医学生物学研究所疫苗研究室云南省重大传染病疫苗研发重点实验室云南省重大传染病疫苗工程技术研究中心,云南省虫媒传染病防控研究重点实验室, 昆明650118

收稿日期:2017-01-16 出版日期:2017-04-25 发布日期:2017-04-25
作者简介:王东宝(1975-),男,主管技师,研究方向:生物制品开发。E-mail:285209690@qq.com
基金资助:
国家科技支撑计划项目(2014BAI01B01);国家重点研究计划生物安全关键技术研究发重点专项(2016YFC1202300)

The Immunity Effect Evluation on Tree Shrew by Hepatitis A Virus Attenuated Live Vaccine, Hepatitis B Vaccine Independently or Combined Adjuvant Heparan Sulfate

WANG Dong-bao, HU Yun-zhang, HU Ning-zhu, HAN Yuan-yuan, KUANG De-xuan, LI Yan-han

Institute of Medical Biology, Chinese Academy of Medical College and Peking Union Medical College,Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases,Yunnan Research Center of Engineering Technique for Vaccines against Severe Infectious Diseases, Yunnan Key Laboratory of Prevention & Control Research on Insect-Borne Infectious Diseases, Kunming 650118, China

Received:2017-01-16 Online:2017-04-25 Published:2017-04-25

摘要/Abstract

摘要： 目的探讨甲型肝炎减毒活疫苗(HepA-l)、乙型肝炎疫苗(Hbv)以及HepA-l、Hbv分别与佐剂硫酸乙酰肝素(HS)联合对树鼩进行免疫后树鼩体液免疫应答的影响。方法按照疫苗种类、佐剂以及免疫途径将树鼩随机分组,同时设空白对照组,分别于末次免疫后的4周、8周、12周、16周和20周尾静脉采血,用ELISA法检测树鼩血清中的特异性IgG抗体水平。结果除空白对照组外,实验组均在末次免疫的第四周检测到抗甲型肝炎病毒(HAV)及抗乙型肝炎病毒(HBV)抗体,抗体水平随着免疫时间延长而逐渐升高并于12周达到峰值,此后逐渐下降。同时,联合HS佐剂组的体液免疫效果均优于单纯疫苗免疫组。并且不同抗原以及联合佐剂采用不同的免疫途径免疫树鼩其免疫效果存在显著性差异。结论通过对树鼩进行疫苗免疫原性和增强免疫效果检测,证实以树鼩作为动物模型进行疫苗评价的可行性。

关键词: 树鼩, 甲型肝炎减毒活疫苗(HepA-l), 乙型肝炎疫苗(Hbv), 硫酸乙酰肝素(HS), 体液免疫

Abstract: Objective To investigate the humoral immune response of tree shrew after the immunization of Hepatitis A attenuated live vaccine (HepA-l)、Hepatitis B vaccine (Hbv) independently and combined with adjuvant heparan sulfate (HS). Methods The tree shrews were randomly divided into 10 groups by the type of vaccine, adjuvant and schedules. The specific IgG levels in sera of tree shrew were determined by ELISA at 4, 8, 12, 16 and 20 weeks after the last immunization respectively. Results Except the blank control group, the anti - hepatitis A virus (HAV) and anti - hepatitis B virus (HBV) antibody was detected in all the experimental group at 4 weeks after last immunization, the level of immune antibody were gradually increased with time and reached the peak at the 12 weeks, then decreased gradually. At the same time, the humoral immunity effect of HS adjuvant group were better than that of vaccine group. There is a significant difference on immunity among tree shrews with different antigens and adjuvant by different immunization schedules. Conclusion The immune effect of vaccine immunogenicity and immune enhancing effect on tree shrew confirms the feasibility of the tree shrew as an animal model.

Key words: Tree shrew, Hepatitis A virus attenuated live vaccine (HepA-l), Hepatitis B vaccine (Hbv), Heparan sulfate (HS), Humoral immunity

中图分类号:

Q95-33

王东宝, 胡云章, 胡凝珠, 罕园园, 匡德宣, 李彦涵. 树鼩经甲型肝炎减毒活疫苗、乙型肝炎疫苗及联合硫酸乙酰肝素佐剂免疫后的免疫效果评价[J]. 实验动物与比较医学, 2017, 37(2): 113-117.

WANG Dong-bao, HU Yun-zhang, HU Ning-zhu, HAN Yuan-yuan, KUANG De-xuan, LI Yan-han. The Immunity Effect Evluation on Tree Shrew by Hepatitis A Virus Attenuated Live Vaccine, Hepatitis B Vaccine Independently or Combined Adjuvant Heparan Sulfate[J]. Laboratory Animal and Comparative Medicine, 2017, 37(2): 113-117.

参考文献

[1] Yang C, Ruan P, Ou C, et al.Chronic hepatitis B virus infection and occurrence of hepatocellular carcinoma in tree shrews (Tupaia belangeri chinensis)[J]. Virol J, 2015, 12:26.
[2] Li SA, LEE WH, Zhang Y.Two bacterial infection models in tree shrew for evaluating the efficacy of antimicrobial agents[J]. Zool Res, 2012, 33(1):1-6.
[3] Tong Y, Zhu Y, Xia Y, et al.Tupaia CD81, SR-BI, claudin, and occludin support hepatitis C virus infection[J]. Virol J, 2011, 85(6):2793-2802.
[4] 黄晓燕, 徐娟, 孙晓梅, 等. 树鼩在人类疾病动物模型中应用研究进展[J], 实验动物科学, 2013, 30(2):59-64.
[5] Bukh J, Lanford RE, Purcell RH.Persistent human hepatitis B virus infection in cynomolgus monkeys:a novel animal model in the search for a cure[J]. Hepatology, 2013, 58(5):1533-1536.
[6] Wang Q, Schwarzenberger P, Yang F, et al.Experimental chronic hepatitis B infection of neonatal tree shrews (Tupaia belangeri chinensis): a model to study molecular causes for susceptibility and disease progression to chronic hepatitis in humans[J]. Virol J, 2012, 9:170.
[7] 严瑞琪, 苏建家, 陈志英, 等. 人乙型肝炎病毒实验感染成年树鼩的初步研究[J]. 广西医学院学报, 1984, 1(1):10-15.
[8] Wang BJ, Tian YJ, Meng ZJ, et al.Establishing a new animal model for hepadnaviral infection: susceptibility of Chinese Marmota species to woodchuck hepatitis virus infection[J]. Gen Virol, 2011,92(3):681-691.
[9] He W, Ren B, Mao F, et al.Hepatitis D virus infection of mice expressing human sodium taurocholate co-transporting polypeptide[J]. PLoS Pathog, 2015, 11(4):e1004840.
[10] Bility MT, Cheng L, Zhang Z, et al.Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages[J]. PLoS Pathog, 2014, 10(3):e1004032.
[11] Walter E, Keist R, Niederost B, et al.Hepatitis infection of tupaia hepatocytes in vitro and in vivo[J]. Hepatology, 1996, 24(1):1-5.
[12] Fan Y, Huang ZY, Cao CC, et al.Genome of the Chinese tree shrew[J]. Nat Commun, 2013, 4:1426.
[13] Fan Y, Yu D, Yao YG.Tree shrew database (Tree shrew DB): agenomic knowledge base for the Chinese tree shrew[J]. Sci Rep, 2014, 4:7145.
[14] 李海燕, 黎家敏, 李靖潇, 等. 高糖高脂饲料联合地塞米松诱发树鼩血糖、血脂异常[J]. 实验动物与比较医学, 2010, 30(3):197-200.
[15] Meng BH, Liu H, Liang Y, et al.Investigation of pathogenesis of diabetic myopathy of skeletal muscle in experimental type I diabetes mellitus of tree shrews[J]. Chin J Diabetes, 2005, 13(4):290-292.
[16] 江勤芳, 匡德宣, 仝品芬, 等. 树鼩规模化繁殖及繁殖群建立[J]. 实验动物科学, 2010, 28(6):35-38.
[17] 兰芸, 王海漩, 乌美妮, 等. 内源性危险信号低分子量硫酸乙酰肝素的免疫佐剂作用[J]. 中国生物制品学杂志, 2011, 24(1):5-9.
[18] 施建东, 胡凝珠, 赵蕊蕊, 等. 氢氧化锌与低分子量透明质酸复合佐剂对甲肝乙肝联合抗原的体液免疫增强作用[J]. 中国生物制品学杂志, 2012, 25(1):34-36.
[19] 梁亮, 李媛, 岳慧芬, 等. 用人工繁殖的围生期和幼年期树鼩感染人乙型肝炎病毒的初步研究[J]. 中国人兽共患病学报, 2006, 22(8):792-795.
[20] Powell JD, Horton MR.Threat matrix: low-molecular-weight hyaluronan(HA)as a danger signal[J]. Immunol Res, 2005, 31(3):207-218.

树鼩经甲型肝炎减毒活疫苗、乙型肝炎疫苗及联合硫酸乙酰肝素佐剂免疫后的免疫效果评价

The Immunity Effect Evluation on Tree Shrew by Hepatitis A Virus Attenuated Live Vaccine, Hepatitis B Vaccine Independently or Combined Adjuvant Heparan Sulfate

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李竹欣, 梁亮, 曹颖颖, 翟珊珊, 戴颖涵, 何夏, 陶俊宇, 冷静, 唐海波. 一例瑶山亚种树鼩原发多形性脂肪肉瘤的诊断[J]. 实验动物与比较医学, 2023, 43(6): 647-653.
[2]	翟珊珊, 梁亮, 曹颖颖, 李竹欣, 王青, 陶俊宇, 运晨霞, 冷静, 唐海波. 一例树鼩毛发上皮瘤的诊断及细胞生物学特性观察[J]. 实验动物与比较医学, 2023, 43(4): 440-445.
[3]	施梅言, 王璇, 王文广, 阮蕾颖, 代解杰. 树鼩脊髓微血管内皮细胞的分离培养及EV71感染实验[J]. 实验动物与比较医学, 2021, 41(2): 148-154.
[4]	李晓飞, 孙晓梅, 王文广, 匡德宣, 陆彩霞, 仝品芬, 罕园园, 李娜, 代解杰. 树鼩连接黏附分子A的基因克隆及初步功能研究#br#[J]. 实验动物与比较医学, 2020, 40(3): 196-.
[5]	李明学, 黎晓慧, 黄鑫, 王璇, 张志成, 袁园, 陆彩霞, 孙晓梅. 树鼩大脑皮层少突胶质前体细胞的分离鉴定[J]. 实验动物与比较医学, 2019, 39(4): 260-266.
[6]	王文广, 匡德宣, 李娜, 陆彩霞, 罕园园, 仝品芬, 孙晓梅, 代解杰. 树鼩Mfsd2a基因的克隆分析和不同组织表达量的检测[J]. 实验动物与比较医学, 2019, 39(3): 178-186.
[7]	王文广, 匡德宣, 陆彩霞, 罕园园, 李娜, 仝品芬, 孙晓梅, 代解杰. 树鼩肺成纤维细胞的分离、鉴定和传代培养[J]. 实验动物与比较医学, 2019, 39(2): 105-110.
[8]	贾杰, 代解杰. 树鼩在生物医学研究中的优势与挑战[J]. 实验动物与比较医学, 2019, 39(1): 3-8.
[9]	张志成, 宋庆凯, 黎晓慧, 李娜, 黄鑫, 袁圆, 王璇, 李明学, 代解杰. MPTP诱导树鼩帕金森疾病模型行为学检测方法研究[J]. 实验动物与比较医学, 2019, 39(1): 9-14.
[10]	王璇, 王文广, 李娜, 袁园, 张志成, 孙晓梅. 树鼩脊髓星形胶质细胞的分离鉴定[J]. 实验动物与比较医学, 2019, 39(1): 15-20.
[11]	李晓红, 金晓, 贾森泉, 胡凝珠, 胡云章, 李建芳. 壬二酸佐剂对甲型肝炎减毒活疫苗诱导小鼠体液免疫应答效应分析[J]. 实验动物与比较医学, 2018, 38(2): 105-110.
[12]	贾森泉, 金晓, 李晓红, 王海璇, 胡凝珠, 胡云章. 硒化卡拉胶对甲型肝炎减毒活疫苗诱导的小鼠体液免疫应答的影响[J]. 实验动物与比较医学, 2018, 38(2): 111-116.
[13]	刘城秀, 李娜, 仝品芬, 王文广, 陆彩霞, 罕园园, 匡德宣, 孙晓梅, 代解杰. 封闭群树鼩的微卫星遗传特性分析[J]. 实验动物与比较医学, 2018, 38(1): 1-9.
[14]	苗雨润, 李娜, 匡德宣, 宋庆凯, 袁圆, 王璇, 张志成, 陆彩霞. 体外诱导树鼩骨髓间充质干细胞向神经元样细胞分化的实验研究[J]. 实验动物与比较医学, 2017, 37(5): 337-343.
[15]	李彦涵, 李建芳, 孙静, 乌美妮, 王海璇, 胡云章. 应用树鼩对硫酸乙酰肝素佐剂的安全性初步评价[J]. 实验动物与比较医学, 2017, 37(5): 390-394.